Bio-based polyhydroxyalkanoates (PHAs) are considered one of the most promising sustainable alternatives to fossil-derived ...
BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) is a clinical-stage biotechnology company focused on transforming the multibillion-dollar spine fusion and bone regeneration market ...
Matthew Downham, CEPI’s director of manufacturing and supply chain networks, tells GEN, “Through this partnership, CEPI and Samsung Biologics will establish a pre-agreed, ready-to-activate ...
Dutch food tech startup Vivici has launched its animal-free lactoferrin protein under the Vivitein brand, after self-determining its GRAS status in the US.
Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state of the art 78,000 square foot facility located in Costa Mesa, ...
Citius Oncology Inc. (NASDAQ:CTOR) develops and commercializes innovative targeted oncology therapies. It also develops LYMPHIR, an orphan indication for the treatment of adult patients with relapsed ...
DENVER, (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial ...
The global biopharmaceuticals market is projected to grow at a compound annual growth rate (CAGR) of approximately 12% over ...
Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.
LOARGYS is the first and only therapy proven to lower arginine in patients 2 years of age and older living with ARG1-D -- ARG1-D is an ultra-rare, debilitating, and progressive metabolic disease ...
ANN ARBOR, Mich., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) in a precedential decision on Friday reversed a district court’s ...